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cryo-EMAmong a panel of 788 clinical inﬂuenza H3N2 isolates, two isolates were characterized by an oseltamivir-
resistant phenotype linked to the absence of any detectable NA activity. Here, we established that the two
H3NA− isolates lack any detectable full-length NA segment, and one of these could be rescued by reverse
genetics in the absence of any NA segment sequence. We found that the absence of NA segment induced a
moderate growth defect of the H3NA− viruses as on cultured cells. The glycoproteins density at the surface
of H3NA− virions was unchanged as compared to H3N2 virions. The HA protein as well as residues 188 and
617 of the PB1 protein were shown to be strong determinants of the ability of H3NA− viruses to grow in the
absence of the NA segment. The signiﬁcance of these ﬁndings about naturally occurring seven-segment
inﬂuenza A viruses is discussed.1.fr (V. Moules).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Human inﬂuenza viruses are responsible for mild to severe res-
piratory tract infections. Inﬂuenza A viruses present two major sur-
face glycoproteins, the hemagglutinin (HA) and the neuraminidase
(NA). The HA is a trimeric type 1 membrane glycoprotein involved in
the binding to cell surface sialoconjugate receptors and in the fusion
between the viral envelope and cellular endosomal membranes. The
NA removes sialic acids from the HA protein as well as from cellular
glycolipids or glycoproteins, thereby preventing the aggregation
of virus particles and allowing the release of virus from host cell
receptors (Palese et al., 1974). The sialidase activity of the NAmay also
enable the virus to diffuse through the abundant mucin layer at the
surface of the respiratory epithelium. An optimal balance betweenthe sialic-acid binding activity of the HA and the sialidase activity of
the NA appears critical for viral ﬁtness (Mitnaul et al., 2000; Wagner
et al., 2002).
The control of human seasonal inﬂuenza can be achieved by vac-
cination or by the use of speciﬁc antivirals. However, in the context of a
pandemic, as illustrated by the current swine-origin H1N1 pandemic,
vaccines are generally not available during the ﬁrst phase and the
use of antivirals is considered the best treatment option during this
initial period. Since 1999, neuraminidase inhibitors (NAIs), zanam-
ivir and oseltamivir, have been used in the treatment of seasonal
inﬂuenza. The rate of emergence of resistant isolates after NAI
treatment has been found to range from 0.4% in adults to up to 4%
in children (Whitley et al., 2001; Roberts, 2001). Substitutions on
catalytic or framework residues of the NA active site are responsible
for the cases of resistance observed in vivo on NAI-resistant viruses
recovered from both drug-treated and untreated patients as well as
in vitro on viruses recovered from culture experiments in the presence
of NAI selective pressure (for a review, see Ferraris and Lina, 2008).
Fig. 1. Kinetics of replication in vitro. A. MDCK cells were inoculated with inﬂuenza virus
at a MOI of 0,0001 in EMEM+1 µg/ml of trypsin, A/California/07/04 H3N2, A/Lyon-
CHU/26430/03 H3NA−, A/Reunion/586/04 H3NA−. After 1 h at 34 °C, the superna-
tant was discarded, the cells were washed with PBS 1× and fresh medium was added.
Samples of supernatants were harvested at predeﬁned time points. The virus released
was then quantiﬁed by end point titration. B. MDCK cells were inoculated with
inﬂuenza virus at a MOI of 0.0001 in EMEM+1 µg/ml of trypsine, A/Moscow/10/99
H3N2, A/California/07/04 H3N2, A/Lyon-CHU/26430/03 H3NA−, A/Reunion/586/04
H3NA−. After 1 h at 34 °C, the supernatant was discarded, the cells were washed with
PBS 1× and fresh medium was added. Samples of supernatants were harvested at
predeﬁned time points. The virus released was then quantiﬁed byM RNA quantiﬁcation
by real time RTPCR. C. MDCK-SIAT 1 cells were inoculated with inﬂuenza virus at a MOI
of 0.0001 in EMEM+1 µg/ml of trypsine, A/Moscow/10/99 H3N2, A/California/07/04
H3N2, A/Lyon-CHU/26430/03 H3NA−, A/Reunion/586/04 H3NA−. After 1 h at 34 °C,
the supernatant was discarded, the cells were washed with PBS 1× and fresh medium
was added. Samples of supernatants were harvested at predeﬁned time points. The
virus released was then quantiﬁed by M RNA quantiﬁcation by real time RTPCR.
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with mutated catalytic residues which showed reduced rates of repli-
cation and transmissibility,with the notable exceptionofH1N1viruses
naturally resistant to oseltamivir that emerged in 2007–2008 (http://
www.who.int/csr/disease/inﬂuenza/2008-9nhemisummaryreport/
en/index.html) (Dharan et al., 2009). In contrast, variants with mu-
tations on framework residues retained an efﬁcient transmissibility
(Gubareva et al., 1998). Moreover, selective pressure in vitro allowed
the recovery of H1N1 viruses with a truncated NA gene segment
lacking the region encoding the NA active site (Nedyalkova et al.,
2002). Such variants with deletions were found to grow on cultured
cells only in the presence of exogenous NA (Hughes et al., 2000).
In this case, HA compensatory mutations are not always observed
(Hughes et al., 2000; Gubareva et al., 2001). However, substitution on
HA gene that may lead to a reduce MDCK receptors binding and a
decreased dependence on NA activity has already been observed and
may lead tomechanism of resistance (McKimm-Breschkin et al., 1996;
Abed et al., 2002).
In a previous study, we analyzed the susceptibility to NAIs of
human inﬂuenza A and B viruses isolated in patients presenting with
acute respiratory infection between 2002 and 2005 (Ferraris et al.,
2006). Overall, 788 viruses were tested for their NA activity using
a ﬂuorometric assay. We detected two H3 viruses that did not show
any detectable NA activity even in the absence of NAI the A/Lyon-
CHU/26430/03 and A/Reunion/586/04 isolates, antigenically related
to A/Wyoming/3/03 and A/Wellington/1/04, respectively (Ferraris
et al., 2006). Attempts to amplify the NA gene and to detect the NA
protein by Western blot on the initial clinical samples as well as on
ampliﬁed viruses both failed (Ferraris et al., 2006).
In the present study, we further characterized the two H3NA− A/
Lyon-CHU/26430/03 and A/Reunion/586/04 isolates. We estab-
lished that they lack any detectable full-length or partial-length NA
segment, and that a recombinant A/Reunion/586/04 virus can be
produced by reverse genetics in the absence of the NA segment. We
examined the impact of the absence of NA segment and NA protein on
the growth properties and the morphology of the H3NA− viruses as
compared to H3N2 counterparts, and we investigated the molecular
basis of their ability to grow in the absence of the NA segment.
Results
Growth kinetics of H3NA− viruses on cultured cells
Two inﬂuenza viruses, A/Lyon-CHU/26430/03 and A/Reunion/
586/04, showed no detectable sialidase activity when tested out of
788 A(H3N2) viruses isolated during the 2002–2005 period of time
(Ferraris et al., 2005). From clinical samples, no ampliﬁcation product
could be detected after extraction of viral RNA and RT-PCR ampli-
ﬁcation using both primers speciﬁc for the untranslated regions of
the N2 segment (Hoffmann et al., 2000) and internal N2 primer sets
(data not shown). To further characterize these two H3NA− viruses,
plaque puriﬁcation was performed and 30 plaque-puriﬁed viruses
were analyzed. The absence of any detectable NA activity and any
detectable full-length or partial-length NA segment was conﬁrmed
on all puriﬁed viruses (data not shown), strongly suggesting that
the genome of the A/Lyon-CHU/26430/03 and A/Reunion/586/04
viruses consists of only seven genomic segments.
Upon ampliﬁcation on MDCK cells, the H3NA− viruses showed
properties similar to contemporary H3N2 viruses, i.e. the ability to
agglutinate guinea pig but not chicken erythrocytes, a mild cytopathic
effect, and signiﬁcant replication yields even in the absence of exogenous
bacterial sialidase (data not shown). To compare the growth kinetics of
H3N2 and H3NA− viruses, MDCK cells were inoculated at a multiplicity
of infection (MOI) of 10−4 and the release of viral progeny into the
supernatant was monitored up to 72 h post infection (p.i.) by
determining the infectious titers or by quantifying the amounts of Mgenomic segment (M-vRNA) by real-time RT-PCR. As shown in Fig. 1A,
the infectious titers in the supernatant of MDCK cells infected with the
H3N2referenceA/California/07/04 increasedexponentially and reached
a maximal titer of 107.3 TCID50/ml at 42 h pi. The growth curves of the
two H3NA− viruses A/Lyon-CHU/26430/03 and A/Reunion/586/04
appeared delayed. Titers measured at 24 h pi for the H3NA− viruses
were about 2 log lower compared to A/California/07/04, but maximal
titers measured at 66 h pi were in the same range (about 107.4 TCID50/
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of the M-vRNA in the supernatant of MDCK infected cells showed the
same trend, although maximal concentrations were reached simulta-
neously at 42 h pi for the A/California/07/04 and for H3NA− viruses
(Fig. 1B).AnadditionalH3N2strain,A/Moscow/10/99, showedagrowth
curve very similar to the H3NA− viruses (Fig. 1B).
MDCK cells that stably over-express the human (alpha)2-6
sialyltransferase (MDCK-SIAT1 cells), proved to be a more suitable
system than MDCK cells to monitor the role of neuraminidase during
the growth process (Matrosovich et al., 2003) probably due to the fact
that the high amounts of sialyl-α2,6-Galactose-containing receptors
at the surface of MDCK-SIAT1 cells increase viral dependency on
NA sialidase activity. The kinetics of M-vRNA accumulation in the
supernatant of MDCK-SIAT cells infected with H3N2 and H3NA−
viruses were compared. The maximal concentrations of M vRNA
measured at 68 h pi were about two log higher for the H3N2 strains
(1011.7 copies/ml) as compared to the H3NA− viruses (108.5 and 109.2
copies/ml for the A/Lyon-CHU/26430/03 and A/Reunion/586/04
viruses, respectively) (Fig. 1C). Altogether, our data conﬁrmed that
the H3NA− viruseswere able to replicate in the absence of NA activity
on MDCK-SIAT1 cells, despite 2–3 logs growth defect.
The H3NA− cell growth abilities were also checked by seven
MDCK SIAT1 cell passages showing the viral stability of these viruses
(data not shown).
Morphological analysis of H3NA− virions by cryo-electron microscopy
To determine the impact of the lack of NA segment and NA protein
on viral morphology, ice-embedded virions from puriﬁed A/Califor-
nia/07/04 H3N2, A/Reunion/586/04 H3NA− and A/Lyon-CHU/Fig. 2. Ice-embedded H3N2 and H3NA− inﬂuenza virions observed in cryo-electron microsc
A/Reunion/586/04. B, C, D respectively zoom vignettes of H3N2 A/California/10/04, H3N
indicate the glycoprotein spikes.26430/03 H3NA− were observed by cryo-electron microscopy
(cryo-EM). Two independent viral preparations of each strain were
analyzed. Electron micrographs were recorded under low-dose
conditions at liquid nitrogen temperature with a Technai Sphera
LaB6 200 kV microscope. Images were collected at 30,000× magniﬁ-
cation in a defocus range between 2 and 3 µm. All observed particles
showedglycoprotein spikes protruding from the virion surface (Fig. 2).
We decided against using the classiﬁcation previously proposed by
Harris et al. (2006) based on the observation of the viralmatrix protein
and internal organization by cryo-electron tomography, since these
viral featureswere not clearly visible on cryo-EM samples. Instead, the
virions were classiﬁed by shape into three groups based on the axial
ratios. Viruses with an axial ratio ranging between 1.0 and 1.2, 1.2 and
1.6, or N1.6 were respectively classiﬁed as spherical, spheroidal or
elongated. The three classes of particle shapes were equally repre-
sented for the A/California/07/04 H3N2 viruses, with 37.9% (n=22)
spherical, 32.8% spheroidal (n=19) and 29.3% elongated (n=17)
virions (Fig. 2 and Table 1). In contrast, for the A/Reunion/586/04
H3NA− viruses, only spherical (50%, n=14) and elongated particles
(50%, n=14)were observed (Fig. 2 and Table 1). For the A/Lyon-CHU/
26430/03H3NA− viruses, 70.0% (n=21) of the virionswere spherical
and 30.0% (n=9) were spheroidal (Fig. 2 and Table 1). The spherical
A/California/07/04 particles had a reduced mean diameter (88.5±
9.3 nm) compared to the A/Reunion/586/04 and A/Lyon-CHU/
26430/03 particles (96.6±16.7 and 102.7±10.5 nm, respectively)
(Table 1) whereas no differences in diameter were observed among
spheroidal and elongated virions. These observations were in
agreementwith previously published data on the variability in particle
shape and size of inﬂuenza A viruses (Booy et al., 1985; Fujiyoshi et al.,
1994; Harris et al., 2006).opy, produced and puriﬁed from MDCK cells. A. Representative micrographs of H3NA−
A− A/Reunion/586/04, and A/Lyon-CHU/26430/03. Scale bars 100 nm. Arrows in D
Table 1
Image analysis of viral particles in cryo-EM. Shapes, diameters, axis lengths and determination of GP spike number at the viral surface.
Viruses Shapes, diameters and axis lengths (average±SD, nm) GP spikes
Spherical Spheroidal Elongated 4 GP spacing (average±SD, nm) GP/ 100 nm spherical virion
H3N2
A/California/07/04
(n=58)
37.9% (n=22)
88.5±9.3
32.8% (n=19)
L: 101.4±11.0
l: 72.9±6.0
29.3% (n=17)
L: 126.3±19.5
l: 63.1±7.8
26.9±8.8 (n=100) 695
H3NA-
A/Reunion/586/04
(n=28)
50.0% (n=14)
96.6±16.7
0% (n=0)
–
–
50.0% (n=14)
L: 129.1±17.8
l: 59.7±9.0
27.0±1.7 (n=80) 689
H
A/Lyon-CHU/26430/03
(n=30)
70.0% (n=21)
102.7±10.5
30.0% (n=9)
L: 109.8±11.7
l: 80.6±9.6
0% (n=0)
–
–
28.1±1.3 (n=48) 637
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guishable (Fig. 2D, arrow) between the lipid bilayer and the electron
opaque layer formed by the GP globular heads, allowing us to count
the GPs and tomeasure the average spacing for a group of 4 GPs (4 GP-
spacing). The average spacing measured for the A/California/07/04
H3N2 virus was 26.9±8.8 nm (n=100, Table 1). From this data
we could calculate the average surface corresponding to 4×4 GPs,
and an estimated number of 695 surface GPs for a spherical virion
of 100 nm in diameter. Analysis of the A/Moscow/10/99 H3N2 strain
led to similar ﬁndings (data not shown). The average 4 GP-spacing
measured for the A/Reunion/586/04 andA/Lyon-CHU/26430/03H3NA
− viruses was 27.0±1.7 nm (n=80) and 28.1±1.4 nm (n=48),
respectively, which corresponded to estimated numbers of 689 and
637 surface GPs per spherical virion of 100 nm in diameter, respectively
(Table 1). The average 4 GP-spacing values showed no signiﬁcant
differences between the different shape classes for a given virion
(Table 1), and between the A/California/07/04, A/Reunion/586/04
and A/Lyon-CHU/26430/03 viruses (pN0.01). Altogether, our data
suggest that despite the lack of NA protein, H3NA− viruses display
similar surface GP densities as compared to H3N2 viruses.
Ultrastructural analysis of H3NA− virions by electron microscopy
To investigate the internal organization ofH3NA− viruses, electron
microscopy ultrathin sections of A/Reunion/586/04, A/Lyon-CHU/
26430/03 and A/California/07/04 virions budding fromMDCK cells at
24 h following low-multiplicity infection were compared. Represen-
tative results are shown in Fig. 3. Transversal sections of budding
virions appeared spherical in shape, with a diameter of 90–100 nm,
whereas longitudinal sections virion appeared elongated and pre-
sented different lengths (data not shown), in agreement with our
cryo-EMdata. Themajority of A/California/07/04 transversal sections
showed the same electron dense-dot organization, i.e. a central dot
surrounded by seven other dots (Fig. 3A). Such an organization, each
dot likely representing a viral ribonucleoprotein, has previously
described by Noda et al. (2006). In contrast, a signiﬁcant proportion
of A/Reunion/586/04 and A/Lyon-CHU/26430/03 transversally sec-Fig. 3. Ultrathin section electron microscopy micrographs of budding inﬂuenza H3N2 and H3
Black scale bar: 200 nm.tionedparticles appeared empty, i.e. devoid of any electron-dense dot :
24% (n=410) and 27% (n=466) for A/Reunion/586/04 and A/Lyon-
CHU/26430/03, respectively, compared to 6% (n=453) for A/
California/07/04 (Fig. 3B and C). These observations were in
agreement with the absence of detectable NA segment in the A/
Reunion/586/04 and A/Lyon-CHU/26430/03 viral stocks, and with
the model for selective packaging, according to which packaging of a
full set of genomic segments depends on cis-acting signals present on
each of the eight genomic segments (Fujii et al., 2003).
Reverse genetics analysis of the H3NA− viral phenotype
To conﬁrm the capacity of the A/Reunion/586/04 virus to
replicate in the absence of the NA segment, the cDNAs corresponding
to the seven remaining genomic segments were cloned in the
bidirectional reverse genetics (RG) plasmid pHW2000 (Hoffmann et
al., 2000). A set of eight pHW2000-derived RG plasmids was
constructed for the A/Moscow/10/99 H3N2 strain (MO). The seven
A/Reunion/586/04-derived RG plasmids, either or not supplemented
with the A/Moscow/10/99-derived NA plasmid, were co-transfected
into 293T cells. Co-transfection of eight (whole sets) or seven (whole
sets minus the NA plasmid) A/Moscow/10/99-derived RG plasmids
was used as a control. Transfection supernants were harvested at 72 h
post-transfection and diluted 1/10 to infect conﬂuent monolayers of
MDCK cells. The viral titers and the amounts of M-vRNA inMDCK cells
supernatants were evaluated at 72 h post-infection by real-time RT-
PCR. About 1011 copies of M-vRNA/ml were detected upon transfec-
tion of the eight A/Moscow/10/99-derived RG plasmids (Fig. 4,
MO, hatched bar). In contrast, in the absence of the NA plasmid, no
hemagglutinating activity andM-vRNA concentrations lower than 105
copies/ml were detected (Fig. 4, MO, gray bar). Similar results were
obtained with the A/Wellington/1/04 H3N2 virus (data not shown).
The low M-vRNA levels detected in the absence of NA most likely
corresponded to the detection of residual pHW2000-M plasmid. In
contrast, titers 1011 copies of M-vRNA/ml were detected upon trans-
fection of the seven A/Reunion/586/04-derived RG plasmids (Fig. 4,
R2, gray bar), and the addition of the A/Moscow/10/99-derived NANA− viruses. A. A/California/07/04, B. A/Reunion/586/04, C. A/Lyon-CHU/26430/03.
Fig. 4. R2/MO recombinant viruses titers. Virus titers were expressed as mean log10 M copies/ml, standard errors (SE) from two or more experiments. “MO”: gene of A/Moscow/10/
99 H3N2, “R2”: gene of A/Reunion/586/04 H3NA−, “CPE + or −”: respectively detectable or nondetectable growth, “7+1”: gene composition identical to the seven segments
composition with the addition of the NA segment from A/Moscow/10/99 H3N2 (hatched bar).
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The viral stability of the recombinant R2 viruses has been controlled
after three MDCK cells passages (data not shown).
These data suggested that some genetic features of the A/
Reunion/586/04 genome accounted for its unique ability to grow
efﬁciently in the absence of the NA segment. In order to test for the
presence of such genetic determinants on the HA segment, we
attempted to rescue A/Moscow/10/99×A/Reunion/586/04
(M0×R2) 6:1 reassortant viruses carrying the HA segment from MO
in combination with the PB1, PB2, PA, NP, M, and NS segments from
R2 (5 R2:HA-MO), or the HA segment from R2 in combination with
the PB1, PB2, PA, NP, M, and NS segments from MO (5 MO:HA-R2).
The reverse genetics protocol was as described above. No hemagglu-
tinating activity and M-vRNA concentrations lower than 106 copies/
ml were detected upon viral ampliﬁcation on MDCK cells (Fig. 4, V1
and V2, gray bars). When the A/Moscow/10/99-derived NA plasmid
was added, viral titers for the 5-MO:R2-HA virus increased signiﬁ-
cantly (Fig. 4, V1, hatched bar), whereas viral titers for the 5-R2:MO-
HA virus remained low (Fig. 4, V2, hatched bar). These data suggestedthat the HA segment was necessary but not sufﬁcient to restore the R2
phenotype.
To investigate further the genetic basis of the R2 phenotype, we
attempted to rescue additional 6:1 MO×R2 reassortant viruses,
carrying the R2-HA segment together with various combinations of
MO and R2 segments (V3 to V7 in Fig. 4). Addition of the M and NS
segments of R2 to the R2-HA segment was not sufﬁcient to restore
the R2 phenotype, i.e. a signiﬁcant viral production in the absence of
the NA segment (Fig. 4, V3, gray bar). In contrast, addition of the PB1,
PB2, PA and NS segments did restore the R2 phenotype (Fig. 4, V6,
gray bar), suggesting that at least one of the segments encoding
the polymerase subunits was necessary. Combination of the R2-PB1
segment with the R2-HA segment and the PB2, PA, NP, M and NS
segments fromMO led to a signiﬁcant viral production in the absence
of the NA segment, at levels similar to those observed for the R2
virus (Fig. 4, V7, gray bar). On the other hand, introduction of the MO-
PB1 segment in the R2 background prevented viral production in
the absence of the NA segment (Fig. 4, V4, gray bar), but not in the
presence of the NA segment (Fig. 4, V4, hatched bar). Our data
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the R2-PB1 segment. However, when tested alone in the MO back-
ground, the R2-PB1 segment did not restore the R2 phenotype (Fig. 4,
V5, gray bar). Taken altogether, these data established that the
combination of both the R2-HA and R2-PB1 segments was necessary
and sufﬁcient to confer an MO×R2 reassortant virus the ability to
grow efﬁciently on MDCK cells in the absence of the NA segment.
Analysis of HA sequences of the H3NA− strains
Sequence alignement revealed that the A/Reunion/586/04 and A/
Lyon-CHU/26430/03 isolates differed from the antigenically related
H3N2 reference strains, A/Wellington/1/04 and A/Wyoming/3/03,
respectively, at ﬁve and seven positions, respectively (Fig. 5 and
Table 2). However, only the mutations P103Q and K173E were found
speciﬁc to A/Reunion/586/04 HA protein when compared to both
several 2004 clinical isolates and A/Moscow/10/99 H3N2 reference
strain. Moreover, only one mutation I260M was found speciﬁc to A/
Lyon-CHU/26430/03 when compared to both several 2003 clinical
isolates and A/Moscow/10/99 H3N2 reference strain.
Genetic analysis of PB1 determinants of the H3NA− strains
Four amino acids differ between the PB1 proteins from the A/
Reunion/586/04 and A/Lyon-CHU/26430/03 H3NA− viruses on oneFig. 5. Structural comparison of the RBS of different hemagglutinins. A. Comparison betwee
program Swiss-Pdb Viewer (Guex and Peitsch, 1997) using the human H3 (PDB: 4hmg) st
1996). For clarity, only the RBS of the HA A/Wellington/1/04 is shown, and is represented a
are numbered and represented in licorice, highlighted in royal blue for A/Wellington/1/04 a
A/Lyon-CHU/26430/03. For clarity, only the RBS of the HA A/Wyoming/3/03 is shown, and
acid substitutions are numbered and represented in licorice, highlighted in royal blue for A/W
listed in Table 2.
Table 2
HA amino acid sequence alignment. HA sequence alignement between A/Reunion/586/04, A
strains.
Strains Residue at amino acid position
103 126 128 145 159 173
A/Moscow/10/99 P N T N Y K
A/Wyoming/3/03 P N A K Y K
A/Lyon-CHU/26430/03 P D T K Y K
A/Wellington/1/04 P N T K F K
A/Reunion/586/04 Q N T N F Ehand, and the PB1 protein from the A/Moscow/10/99 H3N2 virus on
the other hand. These amino acid substitutions could potentially
contribute to the ability of H3NA− viruses to grow in the absence of
the NA segment. The K/E (H3NA−/H3N2) substitution at residue 188
is located within the nuclear localization signal of PB1 (Akkina et al.,
1987; Fodor and Smith, 2004). The substitutions, D/N, N/D and Q/R
(H3NA−/H3N2) substitutions at residues 617, 619 and 621, respec-
tively, are located within the interaction domain of PB1 with PB2
(Gonzalez et al., 1996).
In order to identify the residues determinant with respect to the
H3NA− phenotype, we characterized a new series of recombinant 6:1
reassortants which harbored the MO-PB1 segment, either wild-type
or mutated at one or several of residues 188, 617, 619 and 621, in the
R2 background. As mentioned earlier, the reassortant virus harboring
the wild-type MO-PB1 segment in the R2 background did not rep-
licate efﬁciently in the absence of the NA segment (Fig. 6, V4, gray
bar), but it did so in the presence of the NA segment (Fig. 6, V4,
hatched bar). Introduction of the single K188E substitution or the
three D617N, N619D and Q621R substitutions in MO-PB1 did not
allow the recovery of a replication competent A(H3NA−) virus (Fig. 6,
V4.1 and V4.2, gray bars). When the NA segment was added, the
K188E mutant virus was produced at high titers (about 1011 copies of
M-vRNA/ml), whereas the triple 617–619–621 mutant was produced
at low titers (about 107.8 logs copies of M-vRNA/ml), suggesting that
the triple mutation on its own was detrimental (Fig. 6, V4.1 and V4.2,n HA A/Wellington/1/04 and HA A/Reunion/586/04. The HAs were modeled with the
ructure as the template. The image rendering was done using VMD (Humphrey et al.,
s a gray cartoon diagram. The sialic acid appears in orange. The amino acid substitutions
nd red for A A/Reunion/586/04. B. Comparison between HA A/Wyoming/3/03 and HA
is represented as a gray cartoon diagram. The sialic acid appears in orange. The amino
yoming/3/03 and red for A/Lyon-CHU/26430/03. All the amino-acid substitutions are
/Lyon-CHU/26430/03, A/Wellington/1/04, A/Wyoming/3/03 and A/Moscow/10/99
186 189 219 226 227 260 32 150
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Fig. 6. R2/MO PB1 mutant recombinant viruses titers. Virus titers were expressed as mean log10 M copies/ml, standard errors (SE) from two or more experiments. “MO”: gene of A/
Moscow/10/99 H3N2, “R2”: gene of A/Reunion/586/04 H3NA−, “CPE + or−”: respectively detectable or nondetectable growth, “7+1”: gene composition identical to the seven
segments composition with the addition of the NA segment from A/Moscow/10/99 H3N2 (hatched bar). Numbers in the PB1 box correspond to mutations realized in the PB1 gene.
Fig. 7. CAT assays. graybars: NS viral-like RNA(MO=100%); black bars: H3viral-like RNA.
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617–619–621 mutations on MO-PB1 led to an efﬁcient viral pro-
duction in the absence of the NA segment, both when combined with
six R2-derived segments (Fig. 6, V4.3, gray bar) and when combined
with the R2-HA segment and ﬁve MO-derived segments (Fig. 6, V4.4,
gray bar). The effect of a unique substitution at residue 617, 619
or 621 of PB1 was tested, in the background of the MO-PB1:R2
reassortant virus and in combination with the K188E substitution.
All three mutant viruses grew efﬁciently when the NA segment was
added (Fig. 6, V4.5 to V4.7, hatched bards), but the only virus which
grew efﬁciently in the absence of the NA segment was the K188E+
N617D double mutant.
To investigate further the functional differences between the
PB1 proteins from A/Moscow/10/99 (MO) or A/Reunion/586/04
(R2), transient in vivo reconstitution of viral ribonucleoproteins was
performed in the presence of an H3 or an NS viral-like CAT RNA.
Transcription/replication of the viral-like reporter RNAs was deter-
mined by measuring CAT levels in extracts prepared from transfected
293T cells. As shown in Fig. 7, the levels of CAT measured with the R2
proteins were 1 to 2 log higher as compared to theMO proteins.WhenR2-PB1 was expressed in association with the MO-PB2, -PA and -NP
proteins, or conversely when MO-PB1 was expressed in association
with the R2-PB2, PA and NP proteins, intermediate levels of CAT were
measured, indicating that the PB1protein contributed to the difference
observed between the activities of MO- and R2-derived RNPs.
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In the present study, two inﬂuenza isolates, A/Lyon-CHU/26430/03
and A/Reunion/586/04, which showed no detectable sialidase activity
when tested along with 788 additional H3N2 isolates from the 2003
to 2005 period, as described previously (Ferraris et al., 2006), were
further examined. Upon characterization of plaque-puriﬁed progeny
viruses, we clearly established that the A/Lyon-CHU/26430/03 and A/
Reunion/586/04 lacked the integrality of the NA segment and prop-
agated a viral genome composed of seven segments. This property
is unique as compared to previously described NA-defective viruses,
which retain a deleted NA segment throughout serial ampliﬁcations on
cultured cells although they do not express a functional NA protein (Liu
and Air, 1993; Hughes et al., 2000). The ability of the A/Reunion/586/
04 virus, but not the H3N2 reference strain A/Moscow/10/99, to
replicate efﬁciently in the absence of any NA segment sequence was
conﬁrmed using reverse genetics.
The growth kinetics of the A/Lyon-CHU/26430/03 and A/
Reunion/586/04 H3NA− viruses on MDCK and MDCK-SIAT1 cells
were delayed as compared to H3N2 reference strains. The end-point
viral yields were in the same range for H3NA− and H3N2 viruses on
MDCK cells whereas they were about 2–3-log lower for H3NA− as
compared to H3N2 viruses on MDCK-SIAT1 cells, in agreement with
the fact that higher amounts of Sialyl-α2,6-Galactose-containing
receptors at the surface of MDCK-SIAT1 cells increase viral depen-
dency on NA sialidase activity (Matrosovich et al., 2003). In addition
to the absence of sialidase activity, a reduced efﬁciency of genome
packaging probably contributes to the moderate growth defect of
H3NA− viruses. Indeed, upon cryo-EM analysis, an increased
proportion of particles with no visible ribonucleoproteins was
observed in H3NA− (about 25%) as compared to H3N2 viral stocks
(about 6%). The NA segment sequences that are usually retained in the
genome of NA-defective viruses correspond to the non-coding
sequences and sequences encoding the cytoplasmic tail and trans-
membrane region of the NA protein at the 3′ end, and the non-coding
sequences at the 5′ end (Yang et al., 1997). These sequences were
shown to be required for efﬁcient incorporation of the viral genome in
budding particles (Fujii et al., 2003), which is in favor of the existence
of a selective mechanism underlying the concomitant packaging of a
set of eight genomic segments. The increased proportion of empty
particles in the H3NA− viral stocks most probably corresponds to a
packaging defect, due to the absence of NA packaging signals
(Hutchinson et al., 2010).
Published data suggest that the sequences present at the ex-
tremities of inﬂuenza genomic segments might also be required for
viral morphogenesis and stability (Yang et al., 1997; Hughes et al.,
2000; Enami and Enami, 1996). We observed no major morphological
defect of the H3NA− virions upon cryo-EM analysis as compared to
H3N2 viruses. Both H3NA− and H3N2 viruses showed variable shapes
and sizes, in agreement with previously published observations (Booy
et al., 1985; Fujiyoshi et al., 1994; Harris et al., 2006). Most authors
agree that the NA/HA ratio at the surface of inﬂuenza A viruses is
about 1/5 (Harris et al., 2006; Fujiyoshi et al., 1994). The high reso-
lution of cryo-EM allowed us to measure the average spacing of
surface glycoproteins stalks and to extrapolate the surface glycopro-
teins density, precisely enough to detect a ∼20% reduction that could
result from the absence of NA tetramers . Interestingly, our data
revealed no marked difference in the surface glycoprotein density
between H3NA− and H3N2 viruses, which suggested that the surface
density of the H3 was up-regulated in H3NA− as compared to H3N2
viruses. This higher HA density could simply correspond to a steric
compensation of the absence of NA but the existence of other under-
lying mechanisms cannot be excluded.
Using reverse genetics, we established that both the HA and the
PB1 segments of the A/Reunion/586/04 H3NA− virus accounted for
its ability to replicate efﬁciently in the absence of the NA segment.Mutations on the HA that reduce viral binding to sialic acids, and thus
reduce viral dependence on NA activity, have been found to confer
resistance to neuraminidase inhibitors (McKimm-Breschkin et al.,
1996). Such mutations on the HA of H3NA− viruses could also pos-
sibly provide a compensation for the absence of NA protein. HA
sequence alignement revealed that the A/Reunion/586/04 differed
from 2004 clinical samples at two positions. One of these, K173E
substitution, is located on protruding loops in the vicinity of the
receptor binding site, which are predicted to increase the negative
charges at the distal end of the HA, might alter the electrostatic
interactions between viral particles and the cell surface. One sub-
stitution, I260M, has been observed between A/Lyon-CHU/26430/
03 and 2003 clinical samples but no substitutions were speciﬁc to
H3NA− phenotype. In addition to these amino acid substitutions,
increased amounts of carbohydrates on the HA, due to the absence of
desialylation by the NA, may modulate the binding afﬁnity of the HA
to the host receptors and thus may also contribute to the H3NA−
phenotype. Indeed, previous studies have shown that the removal of
sialic acids from oligosaccharides adjacent to the receptor binding
site of the HA by the NA protein increases the hemadsorption activity
of inﬂuenza viruses (Brassard and Lamb, 1997; Tong et al., 1998).
Here, we focused on the contribution of the PB1 segment of the A/
Reunion/586/04 isolate to the ability to grow in the absence of an NA
segment. The PB1 segment encodes three viral proteins. The PB1
protein is an RNA-dependent RNA polymerase and is the core subunit
of the heterotrimeric PB1-PB2-PA polymerase complex that ensures
transcription and replication of the viral genome in the nucleus of
infected cells (Elton et al., 2006). The PB1-F2 protein, which is en-
coded in an alternative reading frame in the A/Reunion/586/04 virus
but not in all inﬂuenza viruses, was found to be a pro-apoptotic and a
virulence factor (Chen et al., 2001), as well as a regulator of the viral
polymerase activity (Mazur et al., 2008). The functions of the third
most recently PB1-encoded protein, a truncated form of the PB1
protein (N40) are largely unknown (Wise et al., 2009). Sequence
alignement between PB1-F2 of H3NA− and H3N2 revealed no amino
acid subtitutions (data not shown). Based on PB1 sequence alignments
and on reverse genetics experiments, we established that the nature
of both residues 188 and 617 of the PB1 protein (corresponding
to residues 148 and 577 of the N40 protein) were determinant with
respect to the ability of the A/Reunion/586/04 isolate to replicate
efﬁciently in the absence of the NA segment. The A/Reunion/586/04-
derived PB1 protein was also found to increase the efﬁciency with
which a viral-like RNA underwent transcription/replication upon
transient reconstitution of viral ribonucleoproteins, compared to the
A/Moscow/10/99-derived PB1 protein. The nature of residue 188,
which is located within a nuclear localization signal of PB1 (Akkina
et al., 1987; Fodor and Smith, 2004), could potentially have an impact
on the nuclear accumulation of PB1, whereas the nature of residue
617, which is located within the interaction domain of PB1 with
PB2, could modulate the assembly and/or stability of the polymerase
complex. Interestingly, a synergistic effect of substitutions at residues
188 and 617 was observed.
How does the observation of an increased polymerase activity
conferred by the PB1 protein of the R2 virus relate to its ability to
grow in the absence of the NA segment remains to be established.
One hypothesis is that an enhanced polymerase activity could
result in an increased expression of the HA protein, which would
allow viral attachment to the target cells despite a lower afﬁnity
of the HA for sialic acids. Such an increased expression of the HA
could account for our observation that the density of glycopro-
teins at the surface of H3NA− virions was unchanged as
compared to H3N2 virions. This hypothesis is also in agreement
with recent reports of an enhanced polymerase activity being
correlated with an increased accumulation of the NA (Wanitchang
et al., 2010) or the HA protein (Marjuki et al., 2007) on the cell
surface. A second hypothesis is that an increased polymerase
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of viral ribonucleoproteins at the assembly site, which would
allow the incorporation of sets of seven genomic segments in
budding particles, despite an overall decrease in the packaging
efﬁciency due to the absence of the NA packaging signals (Fujii et
al., 2003).
Although H3NA− viruses were isolated from nasal swabs in two
patients, the fact that they did not diffuse in the human population,
taken together with our observation of their growth defect on MDCK-
SIAT1 cells as compared to H3N2 viruses, suggest that these viruses
may replicate poorly in vivo. A bacterial co-infection, resulting in the
expression of a bacterial neuraminidase and favoring the multiplica-
tion of H3NA− variants, could not be established from the analysis of
nasal swabs, but cannot be excluded. Thus, it is still uncertain whether
or not the loss of the whole NA segment could represent a mechanism
of emergence of naturally NAI-resistant viruses able to diffuse in
the human population. Most interestingly, analysis of these H3NA−
viruses suggests that molecular features of the PB1 segment could
strongly modulate the HA/NA ratio at the cell surface and thus the
HA/NA balance. By doing so, the PB1 segment could have a signiﬁcant
impact on the virulence, transmissibility and host-range of human
and animal inﬂuenza viruses. The ﬁnding, by us and by others, of an
impact of the PB1 segment on the amount of glycoproteins expressed
at the virions surface may lead to some improvement in the design
of inﬂuenza vaccines in the future (Wanitchang et al., 2010). Finally
our demonstration that H3NA− viruses can be grown in vitro efﬁ-
ciently in the absence of exogenous NA could prove useful for the
development of inﬂuenza-based vectors expressing a heterologous
gene, and complementary to already existing approaches (Shinya
et al., 2004).
Materials and methods
Cells and viruses
Viruses were isolated onMadin-Darby canine kidney (MDCK) cells
from clinical throat or nasal swabs provided by the French national
inﬂuenza monitoring network GROG (Groupes Régionaux d'Observa-
tion de la Grippe, France) to the WHO Collaborating Center for
inﬂuenza (Southern France). They were subsequently ampliﬁed on
MDCK cells (two passages). The reference strains A/Moscow/10/99
H3N2 and A/California/07/04 H3N2 (kindly provided by Dr A. Hay,
NIMR/MRC) were ampliﬁed in the same conditions. MDCK cells were
purchased from Lonza (ATCC, CCL34) andwere passaged twiceweekly
in serum free Ultra-MDCKmedium (Lonza) supplemented with 2 mM
L-glutamine (Sigma Aldrich), penicillin (225 units/ml) and strepto-
mycin (225 µg/ml) (Lonza). MDCK cells over-expressing the 2,6-
sialyltransferase (MDCK-SIAT1 cells) (Matrosovich et al., 2003) were
kindly provided by Professor HD Klenk (Institute of Virology, Philipps
University, Marburg, Germany). When indicated, Clostridium perfrin-
gens NA (Sigma) was added to the infection medium at a ﬁnal con-
centration of 0.002 U/ml.
Cryo-electron microscopy (Cryo-EM), measurement of viral structure
and statistical analysis
Inﬂuenza viruses were puriﬁed by centrifugation on a 20% sucrose
cushion in phosphate-buffered saline. A droplet of viral preparation
was applied on holey carbon grids and vitriﬁed in liquid ethane.
Electron micrographs were recorded under low-dose conditions at
liquid nitrogen temperature with a Technai Sphera LaB6 200KV mi-
croscope. Images were collected at 30,000× magniﬁcation with a
defocus range of 2 µm. The virion diameter and the glycoprotein (GP)
spacing were determined on Cryo-EM micrographs using the ImageJ
software (http://rsbweb.nih.gov/ij/). The GP spike surface density
was calculated as described previously (Yamaguchi et al., 2008;Terrier et al., 2009). Brieﬂy, the spacing distances between four
consecutive GP stalks were measured. Thus, the total GP number
along a 100 nm diameter virion surface was calculated considering
the total surface area (4piR2 with R=50 nm) and the viral surface
corresponding to 4×4=16 GPs. Surface density data were subjected
to ANOVA statistical analysis (http://faculty.vassar.edu/lowry/
VassarStats.html).
Ultrathin section electron microscopy
For ultrastructural analysis, infected cell cultures were ﬁxed in
a 0.1 M sodium cacodylate, 2% glutaraldehyde solution at room
temperature. After three washes in 0.2 M sodium cacodylate buffer,
the samples were post-ﬁxed in an osmium tetroxide solution, stained
with an aqueous solution of uranylacetate, dehydrated in a graded
series of ethanol at room temperature and embedded in epon. After
polymerization, ultrathin sections (65 nm thick) were cut with a
diamond knife and picked up onto copper grids (300 mesh). Post-
staining of the sections was performed on a Leïca Ultrostainer with a
lead citrate solution. After air drying, grids were examined on a Philips
CM 120 transmission electron microscope at an acceleration voltage
of 80 kV.
Viral growth kinetics, end point titration, and quantiﬁcation of viral RNA
MDCK cells were infected at amultiplicity of infection (MOI) of 10−4
TCID50/cell. After a 1-h viral adsorption period, cellswere overlaidwith
Eagle's minimum elementary medium (EMEM, Lonza) supplemented
with1 µg/ml trypsin (Rochediagnostics) and further incubated at34 °C.
Harvested supernatants were centrifuged at 1500×g for 10 min and
stored at −70 °C until analysis. End point-titration assays were
performed on conﬂuent layers of MDCK cells in 96-well plates. Brieﬂy,
50 µl of 10-fold serial dilutions of each virus was inoculated into four
replicate wells. The 96-well microplates were incubated at 34 °C and
the presence of cytopathic effects (CPE) was monitored 3 days later
under the microscope. The presence of virus in supernatants was also
conﬁrmed by hemagglutination tests using guinea pig erythrocytes.
The TCID50 per ml values were determined using the Reed andMuench
statistical method. The amounts of M viral genomic segment (M-
vRNA) were determined by real-time RT-qPCR as described previously
(Bouscambert Duchamp et al., 2010).
Reverse genetics
A/Moscow/10/99 and A/Reunion/586/04 recombinant viruses
were generated by reverse genetics as previously described (Hoffmann
et al., 2000). Brieﬂy, viral RNA was extracted from infected-MDCK cell
culture supernatant using the QIAmp viral RNA minikit (Qiagen)
according to the manufacturer's instructions. Two-step RT-PCR was
carried out for full-length ampliﬁcation of each viral RNA gene segment,
using an inﬂuenza A universal RT primer (Uni-12 primer «3′-
AGCAAAAGCAGG-5′ », Eurogentec, Belgium) and segment-speciﬁc
primers described by Hoffmann et al. (2000). The resulting cDNAs
were cloned into the pHW2000 vector (Hoffmann et al., 2000). Sets of
eight recombinant pHW2000 plasmids were mixed with the Superfect
reagent (Qiagen) in Opti-MEM (GIBCO-BRL), according to the manu-
facturer's instructions, and added to 293T cells in six-well tissue culture
plates. At 48 hpost-transfection, viruses in the culture supernatantwere
harvested and diluted 1/10 in EMEM medium supplemented with
TPCK-trypsin (1 μg/ml) to infect conﬂuent layers of MDCK cells.
Fluorometric NA activity and inhibition tests
The neuraminidase activity was determined by a ﬂuorometric
assay as described previously (Ferraris et al., 2005). Twenty ﬁve
microliters of the viral stocks was serially diluted twofold and
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acetylneuraminic acid (4-MUNANA) substrate (Sigma) at 37 °C for
1 h. The enzymatic reaction was stopped by the addition of 150 µl of
50 mM glycine (pH 10.4). The ﬂuorescence level of the released 4-
methylumbelliferone was determined at an excitation wavelength of
355 nm and an emission wavelength of 460 nm with a BMG Labtek
ﬂuorometer.
Transfections and CAT assays
The pPR-FluA-CAT and pPR-H3-CAT plasmids, which direct the
expression of inﬂuenza NS and H3 viral-like RNAs, respectively have
been described earlier (Labadie et al., 2007). Subconﬂuent mono-
layers of 293T cells in 12 well plates were transfected using the
FUGENE 6 reagent (Roche) according to the manufacturer instruc-
tions. Brieﬂy, mixes of the pHW2000-PB1, -PB2, -PA, -NP (0.5, 0.5, 0.5,
1 μg) and the pPR-FluA-CAT or pPR-H3-CAT plasmid (0.5 μg) were
resuspended in 45 μl of OPTI-MEM medium (Invitrogen) with 5 μl of
FUGENE 6 and were distributed onto cells. Following 24 h of incu-
bation at 37 °C, cell extracts were prepared in 250 μl of the lysis buffer
provided with the CAT ELISA kit (Roche), and tested for CAT levels.
This procedure allows detection of 0.05 ng/ml CAT.
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